At the time of writing, Boston Scientific Corp [BSX] stock is trading at $104.98, up 0.82%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The BSX shares have gain 5.99% over the last week, with a monthly amount glided 7.44%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Boston Scientific Corp [NYSE: BSX] stock has seen the most recent analyst activity on October 03, 2025, when Erste Group downgraded its rating to a Hold. Previously, Oppenheimer upgraded its rating to Outperform on September 08, 2025, and kept the price target unchanged to $125. On June 16, 2025, Leerink Partners initiated with a Outperform rating and assigned a price target of $118 on the stock. Needham upgraded its rating to a Buy but stick to its price target of $113 on April 16, 2025. Deutsche Bank upgraded its rating to a Buy but $108 remained the price target by the analyst firm on January 10, 2025. Needham downgraded its rating to Hold for this stock on October 18, 2024. In a note dated May 30, 2024, Goldman initiated an Buy rating and provided a target price of $90 on this stock.
For the past year, the stock price of Boston Scientific Corp fluctuated between $85.98 and $109.50. Currently, Wall Street analysts expect the stock to reach $127 within the next 12 months. Boston Scientific Corp [NYSE: BSX] shares were valued at $104.98 at the most recent close of the market. An investor can expect a potential return of 20.98% based on the average BSX price forecast.
Analyzing the BSX fundamentals
According to Boston Scientific Corp [NYSE:BSX], the company’s sales were 19.35B for trailing twelve months, which represents an 20.34% jump. Gross Profit Margin for this corporation currently stands at 0.65% with Operating Profit Margin at 0.17%, Pretax Profit Margin comes in at 0.17%, and Net Profit Margin reading is 0.14%. To continue investigating profitability, this company’s Return on Assets is posted at 0.07, Equity is 0.13 and Total Capital is 0.09. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.54.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 103.18 points at the first support level, and at 101.37 for the second support level. However, for the 1st resistance point, the stock is sitting at 106.22, and for the 2nd resistance point, it is at 107.45.
Ratios To Look Out For
It is important to note that Boston Scientific Corp [NYSE:BSX] has a current ratio of 1.51. In addition, the Quick Ratio stands at 0.96 and the Cash Ratio stands at 0.1. Considering the valuation of this stock, the price to sales ratio is 8.04, the price to book ratio is 6.65 and price to earnings (TTM) ratio is 56.15.
Transactions by insiders
Recent insider trading involved Zane Ellen M, Director, that happened on Nov 06 ’25 when 12891.0 shares were sold. EVP & Group Pres, Cardiology, Fitzgerald Joseph Michael completed a deal on Nov 03 ’25 to sell 50000.0 shares. Meanwhile, Officer JOSEPH M FITZGERALD bought 50000.0 shares on Nov 03 ’25.
